Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition

Circulation Research

Volumn 76, Issue 6, 1995, Pages 1071-1078

  Atsma, Douwe E ^a   Bastiaanse, E M Lars ^a   Jerzewski, Anastazia ^a   Van Der Valk, Lizet J M ^a   Van Der Laarse, Arnoud ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

calcium activated neutral protease; cell death; metabolic inhibition; myocytes; protease inhibitors

Indexed keywords

BETA CASEIN; CALCIUM; CALPAIN; CALPASTATIN; DEOXYGLUCOSE; FLUORESCENT DYE; FURA 2 ACETOXYMETHYL ESTER; LACTATE DEHYDROGENASE; LEUPEPTIN; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; SODIUM CYANIDE; TECHNETIUM 99M;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; ION EXCHANGE CHROMATOGRAPHY; METABOLIC INHIBITION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029050869     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.76.6.1071     Document Type: Article

References (40)

1. Nayler WG. The role of calcium in the ischemic myocardium. Am J Pathol. 1981;102:262-270.
2. Steenbergen C, Murphy E, Watts JA, London RE. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat hearts. Circ Res. 1990;66:135-146.
3. 2+ sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion. Am J Physiol. 1981;240:H704-H708.
4. Steenbergen C, Murphy E, Levy L, London RE. Elevation of cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res. 1987;60:700-707.
5. Reddy PA, Anandavalli TE, Anandaraj MPJS. Calcium activated neutral protease (milli- and microCANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD). Clin Chim Acta. 1986;160:281-288.
6. Saito KI, Elce JS, Hamos JE, Nixon RA. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A. 1993;90:2628-2632.
7. Hong SC, Goto Y, Lanzino G, Soleau S, Kassell NF, Lee KS. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke. 1994;25:663-669.
8. Zimmerman U-JP, Schlaepfer A. Calcium-activated neutral protease (CANP) in brain and other tissues. Prog Neurobiol. 1984;23:63-78.
9. 2+ is mediated by the activation of a nonlysosomal proteolytic system. FEBS Lett. 1986;209:139-144.
10. Bronk SF, Gores GJ. pH-Dependent nonlysosomal proteolysis contributes to lethal anoxic injury of rat hepatocytes. Am J Physiol. 1993;264:G744-G751.
11. Nichols JC, Bronk SF, Mellgren RL, Gores GJ. Inhibition of nonlysosomal calcium-dependent proteolysis by glycine during anoxic injury of rat hepatocytes. Gastroenterology. 1994;106:168-176.
12. 2+ and proteolysis in lethal oxidative injury in endothelial cells. Am J Physiol. 1991;261:C889-C896.
13. Lampi KJ, Kadoya K, Azuma M, David LL, Shearer TR. Comparison of cell-permeable calpain inhibitors and E64 in reduction of cataract in cultured rat lenses. Toxicol Appl Pharmacol. 1992;117:53-57.
14. Tolnai S, Korecky B. Calcium-dependent proteolysis and its inhibition in the ischemic rat myocardium. Can J Cardiol. 1986;2:42-47.
15. Yoshida K, Yamasaki Y, Kawashima S. Calpain activity alters in rat myocardial subfractions after ischemia or reperfusion. Biochim Biophys Acta. 1993;1182:215-220.
16. Iizuka K, Kawaguchi H, Kitabatake A. Effects of thiol protease inhibitors on fodrin degradation during hypoxia in cultured myocytes. J Mol Cell Cardiol. 1993;25:1101-1109.
17. Toyo-oka T, Kamishiro T, Gotoh Y, Fumino H, Masaki T, Hosoda S. Temporary salvage of ischemic myocardium by the protease inhibitor bis[ethyl(2R,3R)-3-[(S)-methyl-1-[4-(2,3,4-trimethoxyphenyl-methyl)piperazin-1- ylcarbonyl]butyl-carbonyl]oxiran-2-carboxylate]sulfate. Arzneimitlelforschung. 1986;36:671-675.
18. Bolli R, Cannon RO, Speir E, Goldstein RE, Epstein SE. Role of cellular proteinases in acute myocardial infarction, II: influence of in vivo suppression of myocardial proteolysis by antipain, leupeptin and pepstatin on myocardial infarct size in the rat. J Am Coll Cardiol. 1983;2:681-686.
19. Croall DE, Demartino GN. Calcium-activated neutral protease (calpain) system: structure, function and regulation. Physiol Rev. 1991;71:813-847.
20. Sasaki T, Kikuchi T, Yumoto N, Yoshimura N, Murachi T. Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic substrates. J Biol Chem. 1984;259:12489-12494.
21. Van der Laarse A, Hollaar L, Van der Valk EJM. Release of alpha-hydroxybutyrate dehydrogenase from neonatal rat heart cell cultures exposed to anoxia and reoxygenation: comparison with impairment of structure and function of damaged cardiac cells. Cardiovasc Res. 1979;13:345-353.
22. Blondel B, Royen J, Cheneval JP. Heart cells in culture: a simple method for increasing the proportion of myoblasts. Experimentia. 1971;27:356-358.
23. 2+-activated proteinases from hearts of hypertensive rats. Biochim Biophys Acta. 1985;830:258-266.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193: 265-275.
25. Farmer W, Yuan Z. A continuous fluorescent assay for measuring protease activity using natural protein substrate. Anal Biochem. 1991;197:347-352.
26. Pauwels EKJ, Welling MM, Feitsma RIJ, Atsma DE, Nieuwenhuizen W. The labeling of proteins and LDL with 99m-Tc: a new direct method employing KBH4 and stannous chloride. Nucl Med Biol. 1993;20:825-833.
27. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
28. 2+ exchanger activity in cultured rat cardiomyocytes. Pflugers Arch. 1994;428:296-299.
29. Atkins DL, Rosenthal JK, Krumm PA, Marvin WJ. Application of stereological analysis of cell volume to isolated myocytes in culture with and without adrenergic innervation. Anal Rec. 1991;231:209-217.
30. Van der Laarse A, Hollaar L, Van der Valk EJM, Hamers S. A method to quantitate cell numbers of muscle cells and non-muscle cells in homogenised heart cell cultures. Cardiovasc Res. 1989;23: 928-933.
31. 2+ concentration and pH of diabetic rat myocytes during metabolic inhibition. J Mol Cell Cardiol. 1992;24:435-446.
32. 2+ overload. Am J Physiol. 1992;263: H1262-H1269.
33. Bhatti S, Zimmer G, Bereiter HJ. Enzyme release from chick myocytes during hypoxia and reoxygenation: dependence on pH. J Mol Cell Cardiol. 1989;21:995-1008.
34. Schwartz P, Piper HM, Spahr R, Spieckermann PG. Ultrastructure of cultured adult myocardial cells during anoxia and reoxygenation. Am J Pathol. 1984;115:349-361.
35. Murphy MP, Hohl C, Brierly GP, Altschuld RA. Release of enzymes from adult heart myocytes. Circ Res. 1982;51:560-568.
36. Chacon E, Reece JM, Nieminen AL, Zahrebelski G, Herman B, Lemasters JJ. Distribution of electrical potential, pH, free Ca(2)+, and volume inside cultured adult rabbit cardiac myocytes during chemical hypoxia: a multiparameter digitized confocal microscopic study. Biophys J. 1994;66:942-952.
37. Li Q, Altschuld RA, Stokes BT. Myocyte deenergization and intracellular free calcium dynamics. Am J Physiol. 1988;255:C162-C168.
38. Mehdi S. Cell-penetrating inhibitors of calpain. Trends Biochem Sci. 1991;16:150-153.
39. Toyo-oka T, Kamishiro T, Masaki M, Masaki T. Reduction of experimentally produced acute myocardial infarction by a new synthetic inhibitor, NCO700, against calcium activated neutral protease. Jpn Heart J. 1982;23:829-834.
40. Haga N, Ishibashi T, Abiko Y. Effect of NCO-700, an inhibitor of protease, on myocardial pH decreased by coronary occlusion in dogs. Pharmacology. 1985;31:208-217.